CAS 850330-18-6

Formula: C27H32N4O4S

InChI: InChI=1S/C27H32N4O4S/c1-17-8-4-5-9-20(17)26(32)29-24-12-13-25(22-11-7-6-10-21(22)24)36(34,35)30-23-14-15-31(16-18(23)2)27(33)19(3)28/h4-13,18-19,23,30H,14-16,28H2,1-3H3,(H,29,32)/t18-,19+,23-/m1/s1

InChI key: FABRBEGQMXBELT-SELNLUPBSA-N

SMILES: C[C@@H]1CN(CC[C@H]1NS(=O)(=O)C2=CC=C(C3=CC=CC=C32)NC(=O)C4=CC=CC=C4C)C(=O)[C@H](C)N

ML604086

CAS: 850330-18-6

ML604086 suppresses CCL1 mediated chemotaxis and enhances intracellular Ca2 concentrations.

Formula: C₂₇H₃₂N₄O₄S

Purezza: 99.91%

Colore e forma: White Solid

Peso molecolare: 508.632

Ref: TM-T16111

ML604086

CAS: 850330-18-6

Formula: C₂₇H₃₂N₄O₄S

Peso molecolare: 508.6324

Ref: IN-DA01V43L

ML604086

CAS: 850330-18-6

ML604086 is a molecule with the potential to treat infectious diseases, such as sclerosis. It has been repurposed from its original purpose of being a chemokine receptor antagonist. The molecule binds to chemokine receptors and prevents the binding of chemokines, which are important in immune system function. ML604086 may have the potential to prevent autoimmune disorders by preventing the binding of chemokines that are responsible for the recruitment of inflammatory cells. Strategies for achieving this drug include using ligands that bind only to one receptor or using ligands that are dispensable because they do not affect other aspects of immune system function.

Formula: C₂₇H₃₂N₄O₄S

Purezza: Min. 95%

Peso molecolare: 508.63 g/mol

Ref: 3D-AJB33018